Shendelman Shoshana 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-14 6:52 pm Sale |
2024-08-12 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 7,803,355 6.600% |
-843,536 (-9.76%) |
Filing |
| 2024-03-05 5:42 pm Purchase |
2024-03-01 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 8,646,891 8.200% |
565,946 (+7.00%) |
Filing |
| 2023-11-13 5:10 pm Purchase |
2023-11-09 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 8,080,945 10.100% |
5,568 (+0.07%) |
Filing |
| 2023-04-28 4:30 pm Purchase |
2023-04-26 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 8,075,377 13.300% |
504,542 (+6.66%) |
Filing |
| 2022-10-14 3:28 pm Purchase |
2022-10-12 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 7,570,835 14.900% |
388,279 (+5.41%) |
Filing |
| 2022-01-28 4:33 pm Purchase |
2022-01-25 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 7,182,556 25.000% |
528,290 (+7.94%) |
Filing |
| 2021-04-16 4:37 pm Purchase |
2021-04-13 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 6,654,266 23.800% |
318,209 (+5.02%) |
Filing |
| 2020-08-14 5:25 pm Sale |
2020-08-14 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 6,336,057 26.500% |
-58,027 (-0.91%) |
Filing |
| 2020-06-01 5:06 pm Purchase |
2020-05-28 | 13D | Applied Therapeutics, Inc. APLT |
Shendelman Shoshana | 6,394,084 27.000% |
600,746 (+10.37%) |
Filing |